EVO:NASDAQ
Evotec SE
US$ १.५९
arrow_upward
+१.९२%(+०.०३०) 1D
US$ १.६०
arrow_upward
+०.६३% (+०.०१००)todayPre-market
Closed: सेप्टेम्बर २८, १६:००:०१ GMT-४ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVO...
Open
US$ १.५६
High
US$ १.५९
Low
US$ १.५६
Mkt. cap
५८.०४ करोड
Avg. vol.
१.१३ लाख
Volume
७.९१ हजार
52-wk high
US$ ४.२७
52-wk low
US$ १.५०
EPS
-US$ ०.६३
Beta
१.९२
Shares outstanding
३५.५८ करोड
No. of employees
४ हजार
Open
US$ १.५६
High
US$ १.५९
Low
US$ १.५६
Mkt. cap
५८.०४ करोड
Avg. vol.
१.१३ लाख
Volume
७.९१ हजार
52-wk high
US$ ४.२७
52-wk low
US$ १.५०
EPS
-US$ ०.६३
Beta
१.९२
Shares outstanding
३५.५८ करोड
No. of employees
४ हजार
News stories
From web sources and news partners
TipRanks
·
१ घण्टा पहिले
Evotec SE Announces Chief Scientific Officer Transition as Long-Serving CSO Steps Down
AD HOC NEWS
·
२ घण्टा पहिले
Evotec stock gains 2.45 percent as chief scientist exits
Stock Titan
·
५ घण्टा पहिले
After 16 years, Evotec's science chief is stepping down
Profile
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
About Evotec SE